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Abstract GastrinlCCK, G protein-coupled receptors have been 
shown to mediate proliferative effects of their endogenons li- 
gands. In the present study, we examined the signal transduction 
mechanisms linked to the GICCK, receptor occupancy. We re- 
port here that gastrin stimulates MAP kinase activation in a 
dose- and time-dependent manner, a pathway known to play a key 
role in cell proliferation. We also characterized the molecular 
events, upstream of p21-Ras, that may link the MAP kinase 
pathway to GICCK, receptors. Gastrin induced a rapid and tran- 
sient increase in tyrosine phosphorylation of several proteins in- 
cluding the 2 isoforms (46 and 52 kDa) of the adaptor protein She. 
Phosphorylated She subsequently associated with a complex that 
includes Grb2 and the p21-Ras activator, SOS. Our results also 
indicate that SOS becomes phosphorylated in response to gastrin 
as shown by a reduction in electrophoretic mobility of the protein. 
Tyrosine phosphorylation of She and subsequent complex forma- 
tion with Grb2 and SOS appear to be a common mechanism by 
which tyrosine kinase receptors and the GICCK, G protein- 
coupled receptor stimulate the Ras-dependent MAP kinase path- 
way. 
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1. Introduction 
Gastrin, a regulatory peptide known to be a potent stimulant 
of gastric acid secretion [l], has also been shown to have 
growth-promoting effects on normal and neoplastic gastroin- 
testinal tissues. Trophic effects of gastrin have been reported 
on normal digestive mucosa [2] as well as on colon carcinomas 
‘in vivo’ [3,4]. Gastrin also stimulates the growth of colon, 
gastric and pancreatic cancer cell lines in culture [5-g] as well 
as the colony formation of small cell lung cancer cells [9]. The 
proliferative effect of gastrin have been shown to be mediated 
by the gastrin/CCK, (G/CCK,) receptor in different cellular 
models [8,9] including cells transfected with the human G/ 
CCK, receptor cDNA [lo-121. This receptor which has been 
recently cloned from different species by several laboratories 
[13-161, belongs to the family of G protein-coupled receptors 
which are known to be linked to the phospholipase C/protein 
kinase C (PLCYPKC) pathway. Gastrin-dependent activation 
of the G/ CCK, receptors has been shown to induce phosphat- 
idyl-inositol biphosphate (PIP2) hydrolysis by PLC that results 
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in inositol triphosphate (IP3) and diacylglycerol (DAG) pro- 
duction leading to intracellular Ca*’ mobilization and stimula- 
tion of PKC [17,18]. Gastrin, like many ligands that bind G 
protein-coupled receptors, has also been shown to induce tyro- 
sine kinase activity [19]. 
It is now well established that the MAP kinase (MAPK) 
pathway, stimulated by growth factor receptors with intrinsic 
tyrosine kinase activity or by growth hormone and cytokine 
receptors coupled to cytosolic protein tyrosine kinase, plays an 
important role in cell proliferation and differentiation [20]. P42- 
MAPK and p44-MAPK, also known as ERK-1 and ERK-2 
(Extracellular Regulated kinase-1 and -2) are two members of 
the MAPK family that are activated by phosphorylation on 
both tyrosine and threonine residues [21-231. Both isoforms 
regulate the activity of several proteins involved in cell prolifer- 
ation by phosphorylation on serinelthreonine residues [24]. 
The best characterized pathway coupled to tyrosine kinase 
receptors that leads to MAPK activation, involves the protoon- 
cogene product p21 -Ras, a member of the small GTPases fam- 
ily [24]. P21-Ras is converted from its inactive GDP-bound 
state to its active GTP-bound state upon tyrosine kinase recep- 
tor stimulation. The role of the activated p21-Ras is then to 
target the serine/threonine kinase c-Raf-1 to the plasma mem- 
brane where it can be activated by phosphorylation. Dual spe- 
cific kinases (tyrosinelthreonine kinases) termed MEK (or 
MAPK kinase) are in turn activated by c-Raf-1 and directly 
phosphorylate MAPK. Recently, an alternative pathway that 
activates MEK in a Raf-independent manner, has been shown 
to regulate MAPK activation [25]. 
Recent studies have shown that G protein-coupled receptors 
also stimulate the activation of MAPK in a Raf-dependent or 
-independent manner [26]. However, the precise mechanisms of 
the different pathways used by these receptors to activate 
MAPK are still poorly understood. Several adaptor proteins 
upstream of p21-Ras have been recently identified. These pro- 
teins link the Ras/Raf pathway to tyrosine kinase receptors as 
well as receptors which activate cytosolic tyrosine kinase [27]. 
The three isoforms (46-, 52-, 66-kDa) of the adapter protein She 
(for Src homology 2/alpha-collagen-related) that bind to spe- 
cific phosphotyrosine-containing sequences via its SH2 (for Src 
Homology 2) domains are phosphorylated on tyrosine residues 
upon stimulation of these receptors. Tyrosine-phosphorylated 
She subsequently interacts with the SH2 domains of a second 
intermediate protein of 25 kDa, Grb2 [28,29]. This second 
adapter protein also possess SH3 (for Src Homology 3) do- 
mains which in turn interact with the proline-rich motifs of the 
Ras-GTP/GDP exchange factor, termed SOS [30-351. Several 
receptors (such as EGF-receptor) have also been shown to 
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interact directly with the Grb21Sos complex to activate the Ras 
pathway [31-351. 
It has been shown that the cloned human G/CCK, receptor 
transfected in mouse NIH3T3 fibroblasts stimulated the 
MAPK pathway [ 111. However, the upstream molecular events 
that link this receptor to MAPK activation still remain to be 
elucidated. We have previously shown that gastrin proliferation 
of a tumor-derived pancreatic acinar cell line (AR4-2J) through 
the GICCK, receptor [8]. In the present study, we have analy- 
sed, in this cellular model, the possibility that gastrin might 
activate, upstream of p2 1 -Ras, the complex ShclGrb21Sos that 
leads to MAPK activation. 
2. Materials and methods 
2. I. Cell culture 
AR4-2J cells, originally obtained by Jessop and Hay [36] from a rat 
exocrine pancreatic tumor (azaserine induced), were a gift from Dr. C. 
Logsdon (Ann Arbor, MI). The cells, plated at 75,000 cells/ml, were 
grown in Dulbecco’s modified Eagle’s medium (DMEM), supple- 
mented with 10% fetal calf serum. The medium was changed every 2 
days. 
2.2. Immunoprecipitation 
AR4-2J cells growing in 100 mm culture dishes were serum starved 
in DMEM for 18 h before peptide addition. After stimulation. the cells 
were washed with ice cold buffer A (50 mM HEPES, 150 mM NaCI, 
IO mM EDTA, 10 mM Na,P,O,, 100 mM NaF, 2 mM orthovanadate, 
pH 7.5) and homogenized in 500~1 lysis buffer (buffer A containing 1% 
Triton X-100,0.5 &M phenylmethyisulfonylfluoride, 20 PM leupeitin, 
100 IU/ml Trasvlol) for 15 min at 4°C. The solubilizates were clarified 
by centrifugatiin a; 12,000 x g for IO min at 4°C and immunoprecipi- 
tated with the indicated antibodies preadsorbed on protein-A or pro- 
tein-G sepharose. Samples for immunoblotting were washed twice with 
30 mM HEPES buffer, pH 7.5 containing 30 mM NaCl and 0.1% Triton 
X-100, resuspended in SDS sample buffer and boiled for 5 min. 
2.3. Western Bloriing Analysis 
Whole cell lysates or immunoprecipitates, prepared as described 
above, were separated by SDS-PAGE. Proteins were transfered to 
PVDF membrane (Immobilon PVDF Millipore). Membranes were 
blocked with saline buffer (1 mM Tris, 14 mM NaCl, pH 7.4) contain- 
ing 5% BSA or non-fat dried milk and incubated overnight with the 
indicated antibodies. Membranes were washed 3 times with saline 
buffer containing 0.5% BSA or non-fat dried milk and 1% Triton X-100 
and incubated with [“‘I]protein-A (500,000 cpm/ml) for 1 h at room 
temperature. Membranes were washed and autoradiographed. 
2.4. immune complex assays for MAPK activation 
Cells growing in 60 mm culture dishes were serum starved in DMEM 
for 18 h before peptide addition. Cell lysates were immunoprecipitated 
as described above with anti p42-MAPK or p44-MAPK antibodies. 
Precipitated immune complexes were washed twice in lysis buffer and 
3 times in 20 mM HEPES buffer, pH 7.5 containing 150 mM NaCI, 200 
PM orthovanadate, 0.1% Triton X-100, 10% glycerol, 0.5 mM phen- 
ylmethylsulfonylfluoride, 20 PM leupeptin, 100 IU/ml Trasylol. The 
phosphorylati& was performed for jOmin at room temperature with 
Mvelin Basic Protein (MBP) at 0.2 mp/ml. 10 mM ME Acetate and 
[y3’P]ATP (3000 Ci/mmole). The reactTon was stopped by depositing 
the samples on P8 1 Whatmann chromatography paper immersed in 1% 
orthophosphoric acid. After 3 washes in 1% orthophosphoric acid, the 
radioactivity was counted. 
2.5. Materials 
Human gastrin>.,,,, was purchased from Bachem (Switzerland). 
[‘251]Na (100 mCi/ml) was obtained from Amersham and [y3’P]ATP 
(3000 Gil mmol) from Isotopchim. Myelin Basic Protein (MBP), Pro- 
tein-A sepharoseCL4B, Protein-G sepharose_CL4B, orthovanadate, 
aprotinin, leupeptin, phenylmethylsulfonylfluoride and BSA 7030 were 
purchased from Sigma. Anti-phosphotyrosine and anti-She antibodies 
were from Upstate Biotechnology. Anti-p42-MAPK, anti-p44pMAPK, 
anti-SOS and anti-Grb2 antibodies were obtained from Santa Cruz. 
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3. Results 
3.1. Tyrosine phosphorylation of cellular proteins in response to 
gastrin 
Since tyrosine phosphorylation is believed to play a key role 
in mediating the proliferative effects of many growth factors, 
we examine the effect of gastrin on tyrosine phosphorylation 
of cellular proteins. Serum-starved cells were treated with gas- 
trin and cell lysates were subjected to SDS-PAGE electrophore- 
sis followed by immunoblot analysis using an anti-phosphoty- 
rosine antibody (as described in section 2). As shown in Fig. 
1, treatment of the cells with 10 nM gastrin induces a rapid and 
transient increase in tyrosine phosphorylation of six proteins 
with approximate molecular weights of 123-, 96-, 65-, 55-, 43- 
and 41-kDa. 
For all the proteins, the stimulation reached a peak value 3 
min after peptide addition before decreasing at 5 and 10 min. 
3.2. MAPK activation in gastrin-treated AR4-2J ceils 
To examine whether G/CCK, receptors could mediate stim- 
ulation of the MAPK pathway in AR4-2J cells, we investigated 
the effect of gastrin on MAPK activity by performing immune 
complex assays for MAPK activation (as described in section 
2). As shown in Fig. 2, gastrin stimulated the MAPK activity 
of p42-MAPK in a manner similar to that observed with the 
P123-W 
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Fig. I. Tyrosine phosphorylation of cellular proteins in response to 
gastrin. AR4-2J cells were stimulated with 10 nM gastrin for the times 
indicated. Whole-cell lysates were prepared as described in section 2 
and immunoblotted with an anti-phosphotyrosine antibody. Molecular 
weight markers are indicated on the right. The arrows on the left 
indicate the migration (kDa) of proteins tyrosine-phosphorylated in 
response to gastrin. 
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tyrosine phosphorylation of cellular proteins. The stimulation 
was time- and dose-dependent and maximal phosphorylation 
of the MAPK substrate (MBP) by immunoprecipitated p42- 
MAPK was achieved 335 min after peptide addition (10 nM) 
before decreasing towards the basal level at 10 min. Similar 
results were obtained with p44-MAPK (data not shown). 
A 
IP: aShc 
IB: aPy 
3.3. Tyrosine phosphorylation of She in gustrin-treated AK4-2J 
cell.7 
It has been shown that She proteins are tyrosine 
phosphorylated upon stimulation of tyrosine kinase receptors 
or receptors directly coupled to cytosolic tyrosine kinase. In 
order to determine whether gastrin could induce tyrosine phos- 
phorylation of She via the G/CCK, G protein-coupled recep- 
tor, cell lysates were immunoprecipitated with an anti-She anti- 
body and precipitates were analysed by immunoblot with an 
anti- phosphotyrosine antibody. As shown in Fig. 3, the 46 and 
52-kDa She isoforms were tyrosine phosphorylated upon gas- 
trin stimulation in a time- (A) and dose-dependent manner (B). 
The increase in tyrosine phosphorylation of both isoforms was 
maximal 335 min after addition of 10 nM and decreased after 
10 min. 
Time, min 0 1 3 5 10 30 60 
B 
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3.4. Association of Grb2 with tyrosine phosphorylated She in 
response to gastrin 
Since Grb2 has been shown to interact via its SH2 domains 
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Fig. 2. Time- and dose-dependent activation of p42-MAPK by gastrin. 
Immune complex assays for MAP kinase activity were performed as 
described in section 2. Cells were treated (A) with 10 nM gastrin for the 
times indicated or (B) for 3 min with increasing concentrations of 
gastrin. 
Gastrin, log M C -10 -9 -8 -7 
Fig.3. Tyrosine phosphorylation of She in gastrin-treated AR4-2J cells. 
Cells were incubated with (A) 10 nM gastrin for the times indicated or 
(B) with increasing concentrations of gastrin for 3 min. Cellular pro- 
teins were immunoprecipitated with an anti-She antibody and Western 
blotted with an anti-phosphotyrosine antibody. The arrows indicate the 
migration of precipitated 52- and 46-kDa She. 
with tyrosine-phosphorylated She, we examined the association 
of Grb2 with She in gastrin-treated AR4-2J cells. Cells were 
stimulated with 10 nM gastrin for varying lengths of time and 
lysates immunoprecipitated with the anti-Grb2 antibody. West- 
ern blotting with an anti-phosphotyrosine antibody revealed an 
increased phosphorylation of two proteins coprecipitated with 
Grb2 that migrated with an apparent molecular weight identi- 
cal to the She proteins (Fig. 4A), suggesting the association of 
both She isoforms with Grb2 in response to gastrin. The time- 
dependent stimulation was similar to that observed with the 
tyrosine phosphorylation of She isoforms. To confirm that 
gastrin could stimulate the association of Grb2 with tyrosine 
phosphorylated She, we performed additional experiments. 
Cell lysates were immunoprecipitated with an anti-She anti- 
body and an anti-Grb2 antibody was used for Western blotting. 
As seen in Fig. 4B, a 23 kDa protein recognized by the anti 
Grb2 antibody in Western blots, was coprecipitated with the 
anti-She antibody in a gastrin-dependent manner. The time 
course and dose response of Grb2/Shc association are consis- 
tent with those observed for She phosphorylation and MAPK 
activation induced by gastrin. 
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3.5. Association of Grb2 with SOS in gastrin-treated AR4-2J cells 
It has been established that SOS, the guanyl-nucleotide ex- 
change factor of Ras, can interact with the SH3 domains of 
Grb2. We therefore assessed the association of Grb2 with SOS 
in AR4-2J cells. Immunoprecipitation of cell extracts with an 
anti-Grb2 antibody revealed coprecipitation of a 170 kDa pro- 
tein identified as SOS by immunoblotting using an anti-SOS 
antibody (Fig. SA,B). After gastrin treatment (10 nM) from 1 
to 30 min, an equivalent amount of SOS was coprecipitated with 
the anti Grb2 antibody indicating that gastrin did not affect the 
association of Grb2 with SOS in AR4-2J cells. However, 3 min 
of gastrin stimulation resulted in a reduction of the electro- 
phoretic mobility of coimmunoprecipitated SOS, suggesting that 
gastrin induced SOS phosphorylation in a time- (A) and dose- 
dependent manner (B). The shift in SOS mobility was maximal 
between 3 and 5 min and decreased at 10 min but remained 
detectable for at least 30 min. Similar results were obtained with 
whole cell lysates analyzed by immunoblot with an anti-SOS 
antibody (Fig. 5C). 
4. Discussion 
Tyrosine phosphorylations are believed to play a key role in 
the regulation of cellular growth induced by multiple receptors, 
such as tyrosine kinase receptors, receptors coupled to cytosolic 
tyrosine kinase (growth hormone and cytokine receptors) as 
well as G protein-coupled receptors. 
In the present study, we show that gastrin, which stimulates 
proliferation of a pancreatic tumor cell line (AR4-2J) [7,8], 
A 
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Fig. 4. Association 
gastrin stimulation. 
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0 1 3 5 10 30 
of tyrosine-phosphorylated She with Grb2 upon 
(A) AR4-2J cells were treated for the indicated 
times with 10 nM gastrin. Cell lysates were immunoprecipitated with 
anti-Grb2 antibody and immunoblotted with an anti-phosphotyrosine 
antibody. The migration of coprecipitated 52- and 46-kDa She is indi- 
cated on the left. (B) Cells were stimulated for 3 min with increasing 
concentrations of gastrin or with 10 nM gastrin for varying lengths of 
time. Cell extracts were immunoprecipitated with an anti-She antibody 
and Western blotted with an antLGrb2 antibody. The migration of 
coprecipitated 23 kDa Grb2 is indicated on the left. 
IP: aShc 
IB: aGrb2 
A 
SOS _) 
Time, min 
Gastrin, log M 
C 
SOS _) 
Gastrin, log M c -10 -9 -8 -7 
Time, min 0 1 3 5 10 30 
IP: aGrb2 
18: aSOS 
0 1 3 5 10 30 
IB: aSOS 
B 
IP: aGrb2 
IB: aSOS 
c -10 -9 -0 
Fig. 5. Association of Grb2 with SOS and the increase in electrophoretic 
mobility of SOS in gastrin treated AR4-2J cells. Cells were incubated 
with (A) 10 nM gastrin for the times indicated or (B) for 3 min with 
increasing concentrations of gastrin. Cell lysates were immunoprecipi- 
tated with an anti-Grb2 antibody and the immunoprecipitates were 
Western blotted with an anti-SOS antibody. The migration of coprecip- 
itated 170 kDa SOS is indicated on the left. (C) AR4-2J cells were treated 
for 3 min with increasing concentrations of gastrin or with 10 nM 
gastrin for varying lengths of time. Whole-cell lysates were im- 
munoblotted with an anti-Sos antibody. The migration of 170 kDa SOS 
is indicated by the arrow. 
induces in this model tyrosine phosphorylation of several pro- 
teins including the 2 isoforms (46-, 52-kDa) of the adaptor 
protein, She. Tyrosine phosphorylation of She and subsequent 
complex formation with Grb2 and SOS appears to be the major 
pathway upstream of p21-Ras, that leads to Ras-dependent 
MAPK activation [3740]. 
This is the first report demonstrating that the G/CCK, G 
protein-coupled receptor mediates p46- and p52-She tyrosine 
phosphorylation and their association with the Grb2/Sos com- 
plex. Grb2 recruitment to phosphorylated She was observed 
within 3 min after gastrin stimulation, however, this increase 
in tyrosine phosphorylation of She did not result in a greater 
association between Grb2 and the Ras activator, SOS. Our data 
suggest that Grb2 and SOS exist in a constitutive complex in 
AR4-2J cells and gastrin does not affect the level of Grb2 
complexed with SOS. These results are consistent with those 
observed in several studies with growth factors [30,33,34]. Reg- 
ulation of Grb2/Sos association has been reported for EGF 
receptor stimulation in cells overexpressing Grb2 [41] as well 
as for the occupancy of the T-cell antigen receptor [42]. 
The results of our experiments also indicate that SOS becomes 
phosphorylated in response to gastrin as shown by a reduced 
electrophoretic mobility of the protein. The time course and 
dose response of SOS phosphorylation by gastrin paralleled 
tyrosine phosphorylation of She and its association with the 
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Grb2/Sos complex as well as MAPK activation. Like gastrin, 
several growth factors have been reported to induce the phos- 
phorylation of SOS [32], however, the role of this phosphoryla- 
tion remains to be elucidated. 
Recently it has been reported that in fibroblasts inhibition 
of SOS phosphorylation did not influence the activation of p21- 
Ras nor the interaction between SOS and Grb2ltyrosine 
phosphorylated-She complex [43]. 
In summary, our results clearly demonstrate that phospho- 
rylation of She and its association with the Grb2/Sos complex 
may be one mechanism, upstream of p21-Ras, by which the 
GICCK, G protein-coupled receptor mediates MAPK activa- 
tion. 
AcknowGdgrments: We thank Dr. Karen Kennedy for critical reading 
of the manuscript. This work was supported by the Association pour 
la Recherche sur le Cancer (Grant 2073) and the Conseil Regional 
Midi-Pyrenees (Grant rech/9208647). 
References 
111 Edkins, J.S. (1905) Proc. R. Sot. London Ser. B. 76, 376. 
[2] Johnson, L.R. (1977) Annu. Rev. Physiol. 39, 135158. 
131 Winsett. O.E.. Twonsend. C.M.. Glass. E.J., Rae-Venter. B. and . 1  
Thompson, J.C. (1982) Surg. Forum 33, 384396. 
[4] Lamote, J. and Willems, G. (1988) Regul. Pep. 20, I-9. 
[5] Watson, S.A., Durrant, L.C. and Morris, D.L. (1989) Br. J. Can- 
cer 59, 554558. 
[6] Watson, S.A., Durrant, L.G., Crosbie, J.D. and Morris. D.L. 
(1989) Int. J. Cancer 43, 692-696. 
171 Seva, C., Scemama, J.L., Bastie, M.J., Pradayrol, L. and Vaysse. _ _ 
N. (1990) Cancer Res. 50. 582995833. 
181 Seva. C.. Dickinson. C.J. and Yamada. T. (1994) Science 265. 
L A 410-412. 
[9] Sethi. T., Herget, T., Wu, S.U., Walsh, J.H. and Roaengurt, E. 
(1993) Cancer Res. 53, 5208-5213. 
[lo] Ito, M., Matsui, T., Taniguchi, T., Tsukamoto, T.. Murayama. T.. 
Arima, N., Nakata, H., Chiba, T. and Chiara, K. (1993) J. Biol. 
Chem. 263, 18300~18305. 
[l l] Taniguchi, T., Matsui, T., Ito, M., Murayama, T., Tsukamoto, T., 
Katakami, Y., Chiba, T. and Chiara, K. (1994) Oncogene 9. 861 
867. 
[12] Seufferlein, T., Withers, D.J., Braod, S., Herget, T., Walsh. J.H. 
and Rozengurt, E. (1995) Cell Growth Diff. 6, 3833393. 
[13] Kopin, AS., Lee, Y.-M., McBride, E.W., Miller, L.J., Lu, M., Lin, 
H., Kalowski, L.F. and Beinborn, M. (1992) Proc. Natl. Acad. Sci. 
USA 89, 3605-3609. 
[14] Wank, S.A., Pisenga, J.R. and deweerth, A. (1992) Proc. Nat]. 
Acad. Sci. USA 89, 8691-8695. 
[15] Nakata, H., Matsui, T., Ito, M., Taniguchi, T., Naribayashi. Y., 
Nakamura, A., Kinoshikazu, K., Chiara, K., Hosoda, S. and 
Chiba, T. (1992) Biochem. Biophys. Res. Commun. 187. 1 I51 
1157. 
[16] Wank, S.A., Harkins, R., Jensen, R.T., Shapira, H., deweerth. A. 
and Slattery, T. (1992) Proc. Nat]. Acad. Sci. USA 89, 312553 129. 
[17] Seva, C., Scemama, J.L., Pradayrol, L., Sarfati, P.D. and Vaysse, 
N. (1994) Regul. Pep. 52, 31-38. 
[I81 Bertrand, V., BdStie, M.J., Vaysse, N. and Pradayrol, L. (1994) Int. 
J. Cancer 56, 427432. 
[19] Majumdar, A.P.N. (1990) Am. J. Physiol. 259, G 626630. 
[20] Peraldi, P., Scimeca, J.C., Filloux, C. and Van Obberghen, E. 
(1993) Endocrinology 132, 2578-2585. 
[21] Boulton, T.G., Yancopoulos, G.D., Gregory, J.S., Slaughter, C., 
Moomaw, C., Hsu, J. and Cobb, M.H. (1990) Science 249,6467. 
[22] Boulton, T.G., Nye, S.H., Robbins, D.J., Ip, N.Y., Radziejewska, 
E., Morgenbesser, S.D., DePinho, R.A., Panayotatos, N., Cobb, 
M.H. and Yancopoulos, G.D. (1991) Cell 65, 6633675. 
[23] Anderson, N.G., Maller, J.L., Tonks, N.K. and Sturgill, T.W. 
(1990) Nature 343, 651-653. 
[24] Davis, R.J. (1993) J. Biol. Chem. 268, 14553314556. 
[25] Lange Carter, C.A., Pleiman, C.M., Gardner, A.M., Blumer, K.J. 
and Johnson, G.L. (1993) Science 260, 315-319. 
[26] Malarkey, K., Belham, CM., Paul, A., Grahm, A., McLees, A., 
Scott, P.H. and Plevin, R. (1995) Biochem. J. 309, 361-375. 
[27] Schlessinger, J. (1993) Trends Biochem. Sci. 18, 2733275. 
[28] Rosakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., 
Daly, R., Li, W., Batzer, A., Thomas, S., Brugge. J., Pehcci, P.G., 
Schlessinger, J. and Pawson, T. (1992) Nature 360, 6899692. 
[29] Pelicci, 6., Lanfrancone, L.. Grignani, F., McGlade, J., Carallo, 
F.. Forni. G.. Nicoletti. I.. Gritmani. F.. Pawson. T. and Pehcci. 
P.G. (1992) Cell 70, 93-104. - 
[30] Egan, S.E., Giddings, B.W., Brooks, M.W., Buday, L., Sizeland, 
A.M. and Weinberg. R.A. (1993) Nature 363, 45-51. 
[31] Lowenstein, E.J., Daly, R.: Batzer, A.G., Li, W., Margolis, B., 
Lammers, R., Ullrich, A., Skolnik, E.Y., Bar-Sagi, D. and 
Schlessinger, J. (1992) Cell 70, 431442. 
[32] Rosakis-Adcock, M., Fernley, R., Wade, J., Pawson, T. and 
Bowtell, D. (1993) Nature 363, 83-85. 
[33] Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., 
Bar-Sagi, D., Margolis, B. and Schlessinger, J. (1993) Nature 363, 
85-88. 
[34] Gale, N.W., Kaplan, S., Lowenstein, E.J., Schlessinger, J. and 
Bar-Sagi, D. (1993) Nature 363, 88892. 
[35] Chardin, P., Camonis, J.H., Gale, N.W., Van Aelst, L., Schlessin- 
ger, J., Wigler, R.H. and Bar-Sagi, D. (1993) Science 260, 13388 
1343. 
[36] Jessop, H.W. and Hay, R.S. (1980) In Vitro 16, 212. 
1371 Vanderkuur. J.. Allevato. G., Billestrun. N.. Norstedt. G. and 
L  1  
Carter-Su, C. (1995) J. Biol. Chem. 270: 758777593. 
[3X] Linseman, D.A., Benjamin, C.W. and Jones, D.A. (1995) J. Biol. 
Chem. 270, 12563-12568. 
[3Y] Cazaubon, S.M., Ramos-Morales, F., Fischer, S., Schweighoffer, 
F., Strosberg, A.D. and Couraud, P.O. (1994) J. Biol. Chem. 269, 
24805-24809. 
[40] Ohmichi, M., Sawada, T., Kanda, Y.. Koike, K., Hirota, K., 
Miyake, A. and Saltiel, A.R. (1994) ????? 269, 378333788. 
1411 Budav. L. and Downward. J. (1993) Cell 73. 61 I-620. 
[42] Ravichandran, K.S., Lorenn, U., Shoelson, S.E. and Burakoff, S.J. 
(1995) Mol. Cell. Biol. 15, 593-600. 
[43] De Vries-Smits, A.M., Pronk, G.J., Medema, J.P., Burgering, 
B.M. and Bos, J.L. (1995) Oncogen 10, 919-925. 
